Clinical trial
Renal Sympathetic Modification in Patients With Essential Hypertension
NCT01417221 is registered in ClinicalTrials.gov with The Second Affiliated Hospital of Chongqing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Renal Sympathetic Modification in Patients With Essential Hypertension
- Lead sponsor
- The Second Affiliated Hospital of Chongqing Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2011
- Completion date
- December 31, 2020
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.